Pharmaceutical Markets in the Asia Pacific Region
All Change in the Tiger Economies?
| Publication Date | June 2005 |
|---|---|
| Publisher | Espicom |
| Product Type | Report |
| Pages | 373 |
| ISBN Number | not applicable |
| Product Code | ESP00362 |
Summary
Pharmaceutical Companies Performance Tables 2005" provides a unique opportunity to assess companies' past performance and potential future activity. Use it for competitor analysis, partnering, licensing background, PR and performance benchmarking.
Key Facts:
- 2004 year-end figures
- Contains detailed performance rankings for more than 100 leading pharmaceutical companies
- Includes individual company results
- Provides up to five years of data
- 300+ pages
- Available over the web, Adobe Acrobat pdf, via email or in print.
Key Financial Indicators:
- Pharmaceutical Sales
- Total Revenues
- Cost of Sales
- Operating Income
- Net Income
- Earnings per Share
- R&D Expenditure
- Capital Expenditure
- Return on Capital Employed
- Total Assets
- Foreign Sales
- Employees
Companies are also ranked by
- Productivity
- Profitability
- Research Rates
- Investment Rates
Performance Indicators: (Using Pharmaceutical Sales as an example)
- Companies by Pharmaceutical Sales 2004 (US$ Million)
- Companies by Yearly Change (Local Currency)
- Companies by Five Year Change (Local Currency)
- Five Year Movement of Pharmaceutical Sales (2000 US$ Exchange Rate)
- Five Year Change in Pharmaceutical Sales (Index Numbers)
Content
- Foreword
- Executive Summary
- Regional Overview
- Geographic Data
- Hong Kong
- Indonesia
- Korea
- Malaysia
- Philippines
- Singapore Taiwan
- Thailand
- Vietnam
- Political Data
- Hong Kong
- Indonesia
- Korea
- Malaysia
- Philippines
- Singapore
- Taiwan
- Thailand
- Vietnam
- Economic Data
- Demographics
- Population
- Vital Statistics
- Healthcare Data
- Health Expenditure
- Hospital Services
- Medical Personnel
- Market Data
- Intellectual Property
- Imports
- Domestic Production
- Exports
- Hong Kong
- Healthcare system
- Organisation
- Health Expenditure
- Hospital Authority Expenditure
- Department of Health Expenditure
- Hospital Services
- Hospital Activity
- Ambulatory Care
- Dental Services
- Hospital Authority Outpatient Departments
- Medical Personnel
- Pharmaceutical market
- Current size
- Projections
- Outlook
- Imports
- Domestic Production
- Vida Laboratories
- Hong Kong Association of the Pharmaceutical Industry (HKAPI)
- HKAPI Members
- Leading Drug Manufacturers & Pharmaceuticals
- 2003 Top 10 Manufacturers
- 2003 Top 10 Products
- OTC Products
- Research & Development
- Exports
- Domestic Exports
- Re-exports
- Accessing the Market
- Pharmaceutical Registration
- Traditional Chinese Medicine (TCM
- The Chinese Medicine Council of Hong Kong
- Patent Protection & Intellectual Property Rights
- Patents & generics
- Local concerns
- Pricing and Reimbursement
- Distribution Channels
- Indonesia
- Healthcare system
- Organisation
- Health expenditure
- Public Expenditure
- Hospital Services
- Ambulatory care
- Medical Personnel
- Pharmaceutical market
- Current Size
- Projections
- Outlook
- Imports
- Domestic Production
- Domestic Producers
- Dankos Laboratories
- Darya-Varia Group
- Darya-Varia Group Sales, 1994-2002
- PT Indofarma
- Kalbe Farma
- PT Kimia
- Tempo Scan Pacific
- PT Dexa Medica
- PT Bio Farma
- Exports
- Accessing the Market
- Pharmaceutical Registration
- Therapeutic Products and Narcotics, Psychotropic and Addictive Substance Control Division
- Traditional Medicines, Cosmetics and Complementary Product Control Division
- National Laboratory of Drug and Food Control
- Centre of Drug and Food Investigation
- Approval Times
- Patent Protection & Intellectual Property Rights
- Pricing and Reimbursement
- Wholesalers
- Pharmacies
- Distribution Channels
- Wholesalers
- Pharmacies
- Korea
- Healthcare system
- Healthcare funding
- Healthcare provision
- Health Expenditure
- Medical Insurance Expenditure
- Central Government Expenditure
- Hospital Services
- Inpatient Activity
- Ambulatory Care
- Hospital Outpatient Activity
- Medical Personnel
- Physicians
- Nursing Staff
- Pharmaceutical market
- Current size Projections
- Outlook
- Imports
- Domestic Production
- Korea Pharmaceutical Manufacturers Association
- Korea Research-based Pharmaceutical Industry Association
- Research & Development
- Exports
- Accessing the Market
- Pharmaceutical Affairs Law
- Korean Pharmacopoeia5
- Other Specification Standards
- Other Regulations
- Good Laboratory Practice
- Good Clinical Practice
- Good Manufacturing Practice
- Advertising
- Others
- Regulatory Bodies
- Pharmaceutical Affairs Bureau
- Korean Food & Drug Administration
- Central Pharmaceutical Affairs Council
- Pharmaceutical Registration
- Product Registration
- Clinical Trials
- OTC products
- Post-market Surveillance
- Re-examination Reports
- Adverse Drug Reactions
- Patent Protection & Intellectual Property Rights
- Pharmaceutical Pricing and Reimbursement
- Standard Retail Price (SRP)
- Medical Insurance Price
- Actual Transaction Pricing
- Reimbursement of Imported Drugs
- 2001/2002 Price Cuts
- Distribution Channels
- Prescriber/dispenser Split
- Korea Pharmaceutical Traders Association
- Korea Pharmaceutical Wholesalers Association
- Malaysia
- Healthcare system
- Organisation
- Health Expenditure
- New Health Scheme
- Hospital Services
- Hospital Activity
- Admissions
- Discharges
- Ambulatory Care Attendances
- Medical Personnel
- Pharmaceutical market
- Current size
- Projections
- Outlook
- Imports
- Domestic Production
- Domestic Producers
- Research & Development
- Exports
- Accessing the Market
- Drug Control Authority
- National Pharmaceutical Control Bureau
- Pharmaceutical Registration
- Registration of NCEs
- Registration of Generics
- Registration of Traditional Medicines & OTCs
- Clinical Trials
- MADRAC (ADR reporting)
- Patent Protection & Intellectual Property Rights
- Distribution Channels
- Pharmacies
- Distributors
- Pharmaniaga
- Zuellig Pharma
- Philippines
- Healthcare system
- Organisation
- Health Expenditure
- Hospital Services
- Ambulatory Care
- Medical Personnel
- Government Medical Personnel
- Pharmaceutical market
- Current size
- Projections
- Outlook
- Market Structure
- Generics
- Imports
- Parallel Imports
- Domestic Production
- Domestic Producers
- Multinationals
- Domestic Manufacturers
- Exports
- Accessing the Market
- National Drug Policy
- Pharmaceutical Registration/Drug Approval Process
- Labelling
- Clinical trials
- Fast Track Registrations
- Patent Protection & Intellectual Property Rights
- Counterfeit Drugs
- Distribution Channels
- Distributors
- Singapore
- Healthcare system Organisation
- Health Expenditure
- Government Health Expenditure
- Hospital Services
- Hospital Resources
- Hospital Activity
- Admissions
- Discharges
- Ambulatory Care
- Hospital Outpatient Attendances
- Medical Personnel
- Pharmaceutical market
- Current size
- Projections
- Outlook
- Imports
- Domestic Production
- Domestic Producers
- Drug Houses of Australia (Asia) Pte Ltd
- MerLion Pharmaceuticals
- Multinational Activity
- Aventis
- Eli Lilly
- GlaxoSmithKline
- Merck Sharp & Dohme
- Merck AG
- Pfizer
- Schering-Plough
- Novartis
- Wyeth
- Research & Development
- Multinational Activity
- Accessing the Market
- Pharmaceutical Registration
- Western Medicinal Products
- Traditional Chinese Medicines
- Controlled Drugs
- Clinical Trials
- Post-marketing Surveillance
- Adverse Drug Reaction Monitoring
- Good Manufacturing Practice and Licensing of Premises
- Patent Protection & Intellectual Property Rights
- Singapore Association of Pharmaceutical Industries (SAPI
- Distribution Channels
- Multinational Activity
- Distributors
- Apotheca Marketing Pte Ltd
- Inchcape Marketing Services Ltd
- Taiwan
- Healthcare system
- Organisation
- New health agency under discussion
- Medical Care Network
- National Health Insurance Programme
- Health Expenditure
- Hospital Services
- Accredited hospitals
- Hospital Activity
- Nursing Care
- Ambulatory Care
- Medical Personnel
- Physicians
- Dentists
- Pharmaceutical market
- Current size Projections
- Outlook
- Market Structure
- NHI Pharmaceutical Expenditure
- Generics
- OTC Products
- Imports
- Domestic Production
- China Chemical & Pharmaceutical Co Ltd (CCPC)
- China Chemical Synthesis Industrial Co Ltd (CCSI)
- Dah Feng Capsule Industry Co Ltd
- Everlight Chemical Industrial Company
- Formosa Laboratory
- Genovate Biotechnology Co Ltd
- Leily Biotech
- Nan Kuang Pharmaceutical
- Newai Chemical Industry Co Ltd
- ScinoPharm
- Sinphar Pharmaceuticals
- Syn-Tech Chem & Pharm Co Ltd
- Shin Lih Fang Enterprise Co Ltd
- Sintong Chemical Industrial Co
- Taiwan Panbiotic
- Ying Yuan Chemical Pharmaceutical Co Ltd
- Yung Shim Pharm Ind Co Ltd
- Weidar Chemical & Pharmaceutical Co Ltd
- Multinational Activity
- IRPMA
- Research & Development
- Exports
- Accessing the Market
- Pharmaceutical Registration/Drug Approval Process
- Free Sales Certificates
- Plant Master File
- Good Manufacturing Practice
- Clinical Trials
- Drug testing
- Surveillance System
- Drug Relief Injuries Fund
- Pharmaceutical Certifications
- Patent Protection & Intellectual Property Rights
- New Data Protection Law
- Pharmaceutical Pricing and Reimbursement
- Patient co-payments
- Distribution Channels
- Wholesaling
- Dispensing
- Thailand
- Healthcare system
- Organisation
- Central Administration
- Government Pharmaceutical Organisation
- Health System Research Institute
- Regional/Provincial Administration
- Other Health Providers
- Private Sector
- The Private Hospital Association of Thailand
- Health Expenditure
- Ministry of Public Health Expenditure
- Hospital Services
- Hospital Resources
- Private Hospital Resources
- Hospital Activity
- Ambulatory Care
- Medical Personnel
- Pharmaceutical market
- Current size
- Projections
- Outlook
- Imports
- Domestic Production
- GPO
- Pharmaceutical Producers Association
- Thai Pharmaceutical Manufacturers Association
- Domestic Producers
- ANB Laboratories Co. Ltd
- Atlantic Laboratories Corp., Ltd
- Bayer Laboratories Ltd
- Berlin Pharmaceutical Industry Co., Ltd
- Biolab Co. Ltd
- Chareon Bhaesaj Lab Co., Ltd
- Chinta Trading Co. Ltd
- Community Pharmacy Public Co. Ltd
- Continental-Pharm Co., Ltd
- General Drugs House Co. Ltd
- GlaxoSmithKline
- Lupin Chemicals (Thailand) Co., Ltd
- Medicpharma Co., Ltd
- Merck Ltd
- Schering Chemicals Ltd
- Siamerican Pharmaceuticals Co., Ltd
- Thai Nakorn Patana Co., Ltd
- Thaipharmed 1942 Co., Ltd
- Unison Laboratories Co., Ltd
- Exports
- Accessing the Market
- Thai FDA
- Division of Drug Analysis
- Pharmaceutical Registration/ Drug Approval Process
- Modern Drug Registration
- Traditional Drugs.
- New Drug Registration
- Registered Drugs
- Clinical Trials
- Fast Track Registration
- Post Marketing Surveillance
- Pharmaceutical Pricing and Reimbursement
- Patent Protection & Intellectual Property Rights
- Didanosine patent
- Distribution Channels
- Unofficial Pharmacies
- Distributors
- Vietnam
- Healthcare system
- Organisation
- Health Expenditure
- State health insurance
- Hospital Services
- Private Sector
- Ambulatory Care
- Medical Personnel
- Pharmaceutical market
- Current size
- Projections
- Outlook
- Imports
- Parallel Imports
- Domestic Production
- GMP Compliance
- Ten Year Government Strategy
- Domestic Producers
- Novartis
- Aventis (Rhne Poulenc Rorer
- Sanofi-Synthlabo
- Exports
- Accessing the Market
- Pharmaceutical Registration
- Patent Protection & Intellectual Property Rights
- ompulsory Licensing
- Pricing and Reimbursement
- Distribution Channels
- Appendix 1: Directory
- Hong Kong
- Healthcare Organisations
- Distributors
- Indonesia
- Healthcare Organisations
- Korea
- Healthcare Organisations
- Malaysia
- Healthcare Organisations
- Philippines
- Healthcare Organisations
- Singapore
- Healthcare Organisations
- Taiwan
- Thailand
- Government Organisations
- Trade Associations
- Vietnam
- Healthcare Organisations
- Appendix 2: Trade Code Classifications
- Key to medical device trade categories
- Appendix 3: Sources
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
PRINT/CD-ROM:Despatched within 1 to 2 working days.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















